Chemokine receptors, neural progenitor cells, and the AIDS dementia complex

Journal of Infectious Diseases

Volumn 190, Issue 2, 2004, Pages 211-215

  Kao, Aimee W ^a   Price, Richard W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; PROTEIN P21; PROTEIN P27;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN INJURY; BRAIN SLICE; CEREBROSPINAL FLUID; COLONY FORMATION; EDITORIAL; HIPPOCAMPUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MEDICAL LITERATURE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

AIDS DEMENTIA COMPLEX; BRAIN; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; NEURONS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; STEM CELLS;

EID: 3242698528     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422012     Document Type: Editorial

References (55)

1. Krathwohl MD, Kaiser JL. HIV-1 promotes quiescence in human neural progenitor cells. J Infect Dis 2004; 190:216-26 (in this issue).
2. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239:586-92.
3. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996; 39:705-11.
4. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995; 38:563-70.
5. Wiley CA, Achim CL, Christopherson C, et al. HIV mediates a productive infection of the brain. AIDS 1999; 13:2055-9.
6. Wiley CA, Baldwin M, Achim CL. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 1996; 10:843-7.
7. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002; 186(Suppl 2):S193-8.
8. Albright AV, Soldan SS, Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol 2003; 9:222-7.
9. O'Brien WA, Koyanagi Y, Namazie A, et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990; 348:69-73.
10. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol 1991; 65:3973-85.
11. Gorry PR, Bristol G, Zack JA, et al. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 2001; 75:10073-89.
12. Gorry PR, Taylor J, Holm GH, et al. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol 2002; 76:6277-92.
13. Zheng J, Thylin MR, Ghorpade A, et al. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 1999; 98:185-200.
14. Gabuzda D, Wang J. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 2000; 6(Suppl 1):S24-32.
15. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410:988-94.
16. Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 2002; 82:1311-29.
17. Tran PB, Miller RJ. Chemokine receptors in the brain: a developing story. J Comp Neurol 2003; 457:1-6.
18. Lazarini F, Casanova P, Tham TN, et al. Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur J Neurosci 2000; 12:117-25.
19. Westmoreland SV, Alvarez X, deBakker C, et al. Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J Neuroimmunol 2002; 122:146-58.
20. Stumm RK, Rummel J, Junker V, et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22:5865-78.
21. Stumm RK, Zhou C, Ara T, et al. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 2003; 23:5123-30.
22. Ma Q, Jones D, Borghesani PR, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95:9448-53.
23. Bagri A, Gurney T, He X, et al. The chemokine SDF1 regulates migration of dentate granule cells. Development 2002; 129:4249-60.
24. Bachis A, Mocchetti I. The chemokine receptor CXCR4 and not the N-methyl-D-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells. J Neurosci Res 2004; 75: 75-82.
25. Corasaniti MT, Piccirilli S, Paoletti A, et al. Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor. Neurosci Lett 2001; 312:67-70.
26. Gage FH. Mammalian neural stem cells. Science 2000; 287:1433-8.
27. Fuchs E, Gould E. Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications. Eur J Neurosci 2000; 12:2211-4.
28. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2002; 22:629-34.
29. Kempermann G, Kuhn HG, Gage FH. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Natl Acad Sci USA 1997; 94:10409-14.
30. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. Functional neurogenesis in the adult hippocampus. Nature 2002; 415: 1030-4.
31. Nakatomi H, Kuriu T, Okabe S, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002; 110:429-41.
32. Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science 1994; 264:1145-8.
33. Gould E, Reeves AJ, Graziano MS, Gross CG. Neurogenesis in the neocortex of adult primates. Science 1999; 286:548-52.
34. Gould E, Vail N, Wagers M, Gross CG. Adult-generated hippocampal and neocortical neurons in macaques have a transient existence. Proc Natl Acad Sci USA 2001; 98:10910-7.
35. Kruger GM, Morrison SJ. Brain repair by endogenous progenitors. Cell 2002; 110:399-402.
36. Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002; 417:39-44.
37. Haydon PG. GLIA: listening and talking to the synapse. Nat Rev Neurosci 2001; 2:185-93.
38. Albright AV, Shieh JT, Itoh T, et al. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 1999; 73:205-13.
39. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986; 19:517-24.
40. Price RW. Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS 1995; 9(Suppl A):S221-36.
41. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 19:525-35.
42. Rosenblum MK. Infection of the central nervous system by the human immunodeficiency virus type 1: morphology and relation to syndromes of progressive encephalopathy and myelopathy in patients with AIDS. Pathol Annu 1990; 25:117-69.
43. Petito CK, Roberts B, Cantando JD, Rabinstein A, Duncan R. Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. J Neuropathol Exp Neurol 2001; 60:377-85.
44. Price RW, Sidtis JJ. Evaluation of the AIDS dementia complex in clinical trials. J Acquir Immune Defic Syndr 1990; 3(Suppl 2):S51-60.
45. Budka H. Cerebral pathology in AIDS: a new nomenclature and pathogenetic concepts. Curr Opin Neurol Neurosurg 1992; 5:917-23.
46. Brouwers P, Civitello L, DeCarli C, Wolters P, Sei S. Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. J Neurovirol 2000; 6:390-7.
47. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ. HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group. Neurology 2000; 54: 1089-95.
48. Belman AL. Infants, children and adolescents. In: Berger JR, Levy RM, eds. AIDS and the nervous system. 2nd ed. Philadelphia: Lippincott-Raven, 1997:223-53.
49. Kilby JM, Eron JJ. Novel therapies based on mechanisms of HIV-1 cell entry. N Engl J Med 2003; 348:2228-38.
50. Moore JP, Doms RW. The entry of entry inhibitors: a fusion of science and medicine. Proc Natl Acad Sci USA 2003; 100:10598-602.
51. Pizzo PA, Eddy J, Falloon J, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319:889-96.
52. Sidtis JJ, Gatsonis C, Price RW, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol 1993; 33:343-9.
53. Vago L, Bonetto S, Nebuloni M, et al. Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies. AIDS 2002; 16:1925-8.
54. D'Arminio Monforte A, Cinque P, Mocroft A, et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004; 55:320-8.
55. Valle M, Price RW, Nilsson A, Heyes M, Verotta D. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modeling of dynamics following antiretroviral therapy. Brain 2004; 127:1047-60.